Sermorelin Peptide Consent Form
Please review the information on Sermorelin peptide therapy, acknowledge the potential benefits and warnings, and provide your consent below.
Sermorelin is a peptide similar in structure to growth hormone-releasing hormone (GHRH). It stimulates the pituitary to release adequate amounts of growth hormone in concert with the body's circadian rhythm. Sermorelin acetate is a synthetic peptide similar to the body's Growth Hormone Releasing Hormone. Sermorelin is not FDA approved.
Potential Benefits:
• Improved non-REM sleep which may lead to healthier immune function
• Support improved cognition, especially in the elderly
• Enhanced tissue repair and recovery
• Increased collagen production for healthier skin and nails
• Improved libido
• Support cardiovascular health
• Improved insulin sensitivity
• Enhanced ATP synthesis for better cellular energy regulation
• Boosts physical performance
• Increased bone mineral density
• Increase in muscle mass paired with fat loss (improved body composition)
Warnings:
• Avoid in pregnancy or breastfeeding. There is insufficient data to support use in these subpopulations.
• Avoid use in patients with a current or past diagnosis of cancer, especially hormone-related tumors.
• Medication may not provide a benefit in patients with chronic IGF-1 elevations.
By signing below, you acknowledge that you have read and understood the information above, are aware of the potential risks and benefits, deny a history of cancer, and confirm you are not pregnant or breastfeeding.
Patient Full Name
*
First Name
Last Name
Patient Signature
*
Date (Patient)
*
-
Month
-
Day
Year
Date
Provider Name
*
First Name
Last Name
Date (Provider)
*
-
Month
-
Day
Year
Date
Submit Consent
Submit Consent
Should be Empty: